Matches in Wikidata for { <http://www.wikidata.org/entity/Q92059096> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92059096 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92059096 description "im Mai 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92059096 description "scientific article published on 15 May 2019" @default.
- Q92059096 description "wetenschappelijk artikel" @default.
- Q92059096 description "наукова стаття, опублікована 15 травня 2019" @default.
- Q92059096 description "գիտական հոդված հրատարակված 2019 թվականի մայիսի 15-ին" @default.
- Q92059096 name "Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis" @default.
- Q92059096 name "Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis" @default.
- Q92059096 type Item @default.
- Q92059096 label "Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis" @default.
- Q92059096 label "Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis" @default.
- Q92059096 prefLabel "Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis" @default.
- Q92059096 prefLabel "Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis" @default.
- Q92059096 P1433 Q92059096-3141A9C8-801B-425D-BAC0-AFAD3CF73BB5 @default.
- Q92059096 P1476 Q92059096-91A87E2E-6A4C-496D-9BCD-DBC53263E1A9 @default.
- Q92059096 P2093 Q92059096-5C5F5464-E910-4335-9D5A-6D2898FC4CE3 @default.
- Q92059096 P2093 Q92059096-8CCDFE39-6811-49F3-81AD-0E7369B5F0C1 @default.
- Q92059096 P2093 Q92059096-9ED03F8D-4540-4FFB-85FA-253693CC4D37 @default.
- Q92059096 P2093 Q92059096-BA5A3CF5-5F76-4CBD-8422-81FABECEB274 @default.
- Q92059096 P2093 Q92059096-D9818A6B-4629-4E80-B259-0E1818BA9A95 @default.
- Q92059096 P304 Q92059096-11F65034-5329-48A2-BDBA-9D66C33002C9 @default.
- Q92059096 P31 Q92059096-1D4034EE-197D-421B-BC0E-8219C91D412C @default.
- Q92059096 P356 Q92059096-BB1ED8BE-B53B-4A14-816A-924EB86D3757 @default.
- Q92059096 P433 Q92059096-A17E022F-D0F3-4915-80A3-F732635CD406 @default.
- Q92059096 P478 Q92059096-25A60740-F3C4-4161-868B-5242FC9CA3C9 @default.
- Q92059096 P50 Q92059096-4FAF1AB7-5BCB-420B-8EC7-AF0555D6E077 @default.
- Q92059096 P50 Q92059096-E220347F-7345-4B48-8054-1C9DA78E12CF @default.
- Q92059096 P577 Q92059096-C9423D55-2E9B-4C13-AF52-0E3EA748B2AC @default.
- Q92059096 P698 Q92059096-B2720ECE-9BF5-47A4-B792-90B27B31E0CD @default.
- Q92059096 P921 Q92059096-66CF4782-CBE9-4C54-B1CC-118D8CDD38AC @default.
- Q92059096 P921 Q92059096-96F832F8-153D-4DD7-B90A-5FDCE824EA7B @default.
- Q92059096 P921 Q92059096-FF13FFE4-5979-4AED-900E-75825F1A6C90 @default.
- Q92059096 P356 S00277-019-03708-9 @default.
- Q92059096 P698 31093708 @default.
- Q92059096 P1433 Q15766509 @default.
- Q92059096 P1476 "Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis" @default.
- Q92059096 P2093 "Ala Abudayyeh" @default.
- Q92059096 P2093 "Maen Abdelrahim" @default.
- Q92059096 P2093 "Sherry A Pierce" @default.
- Q92059096 P2093 "Umut Selamet" @default.
- Q92059096 P2093 "Valda D Page" @default.
- Q92059096 P304 "1611-1616" @default.
- Q92059096 P31 Q13442814 @default.
- Q92059096 P356 "10.1007/S00277-019-03708-9" @default.
- Q92059096 P433 "7" @default.
- Q92059096 P478 "98" @default.
- Q92059096 P50 Q64026418 @default.
- Q92059096 P50 Q88235136 @default.
- Q92059096 P577 "2019-05-15T00:00:00Z" @default.
- Q92059096 P698 "31093708" @default.
- Q92059096 P921 Q1752571 @default.
- Q92059096 P921 Q3857106 @default.
- Q92059096 P921 Q7383611 @default.